Deeper Knowledge, Faster

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Baxter
Cipla
Deloitte
Moodys
Covington
Merck
Healthtrust
Fuji
Medtronic

Generated: January 16, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 061905

« Back to Dashboard

NDA 061905 describes E.E.S. 400, which is a drug marketed by Arbor Pharms Llc and is included in two NDAs. It is available from one supplier. Additional details are available on the E.E.S. 400 profile page.

The generic ingredient in E.E.S. 400 is erythromycin ethylsuccinate. There are ninety-nine drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the erythromycin ethylsuccinate profile page.
Summary for 061905
Tradename:E.E.S. 400
Applicant:Arbor Pharms Llc
Ingredient:erythromycin ethylsuccinate
Patents:0
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details
Pharmacology for NDA: 061905
Ingredient-typeMacrolides
Physiological EffectDecreased Sebaceous Gland Activity
Suppliers and Packaging for NDA: 061905
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
E.E.S. 400 erythromycin ethylsuccinate TABLET;ORAL 061905 ANDA Arbor Pharmaceuticals, Inc. 24338-100 24338-100-13 100 TABLET in 1 BOTTLE (24338-100-13)

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrengthEQ 400MG BASE
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 400MG BASE
Approval Date:Aug 12, 1982TE:BXRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
McKesson
Fish and Richardson
Baxter
Moodys
Colorcon
Novartis
Mallinckrodt
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot